New England Spinal Metastatic Score (NESMS)
Prognostication of mortality in patients with spinal metastases.
Author / Source: William Giles
The New England Metastatic Spinal Score (NESMS) is a prognostic tool for survival in
patients with spinal metastases. It is helpful for guiding clinicians in their decision
making, and enabling patients to better understand the outcomes associated with their
spinal metastasis.
Numerous studies have found NESMS to be superior to alternative legacy prognostic
scores such as Tokuhashi, Bauer, Tomita and SINS.
- [1]Schoenfeld AJ, Ferrone ML, Blucher JA, et al.: Prospective comparison of the accuracy of the New England Spinal Metastasis Score (NESMS) to legacy scoring systems in prognosticating outcomes following treatment of spinal metastases.Spine J. 2022;22(1):39-48. doi:10.1016/j.spinee.2021.03.007
- [2]Schoenfeld AJ, Le HV, Marjoua Y, et al.: Assessing the utility of a clinical prediction score regarding 30-day morbidity and mortality following metastatic spinal surgery: the New England Spinal Metastasis Score (NESMS).Spine J. 2016;16(4):482-490. doi:10.1016/j.spinee.2015.09.043
- [3]Schoenfeld AJ, Ferrone ML, Schwab JH, et al.: Prospective validation of a clinical prediction score for survival in patients with spinal metastases: the New England Spinal Metastasis Score.Spine J. 2021;21(1):28-36. doi:10.1016/j.spinee.2020.02.009
- [4]Xiong GX, Fisher MWA, Schwab JH, et al.: A Natural History of Patients Treated Operatively and Nonoperatively for Spinal Metastases Over 2Years Following Treatment: Survival and Functional Outcomes.Spine (Phila Pa 1976). 2022;47(7):515-522. doi:10.1097/BRS.0000000000004322
- [5]Wick JB, Kalistratova VS, Jr DP, et al.: A Comparison of Prognostic Models to Facilitate Surgical Decision-Making for Patients With Spinal Metastatic Disease.Spine (Phila Pa 1976). 2023;48(8):567-576. doi:10.1097/BRS.0000000000004600
Results
Real-time automated computation
The New England Metastatic Spinal Score (NESMS) is a prognostic tool for survival in
patients with spinal metastases. It is helpful for guiding clinicians in their decision
making, and enabling patients to better understand the outcomes associated with their
spinal metastasis.
Numerous studies have found NESMS to be superior to alternative legacy prognostic
scores such as Tokuhashi, Bauer, Tomita and SINS.
- [1]Schoenfeld AJ, Ferrone ML, Blucher JA, et al.: Prospective comparison of the accuracy of the New England Spinal Metastasis Score (NESMS) to legacy scoring systems in prognosticating outcomes following treatment of spinal metastases.Spine J. 2022;22(1):39-48. doi:10.1016/j.spinee.2021.03.007
- [2]Schoenfeld AJ, Le HV, Marjoua Y, et al.: Assessing the utility of a clinical prediction score regarding 30-day morbidity and mortality following metastatic spinal surgery: the New England Spinal Metastasis Score (NESMS).Spine J. 2016;16(4):482-490. doi:10.1016/j.spinee.2015.09.043
- [3]Schoenfeld AJ, Ferrone ML, Schwab JH, et al.: Prospective validation of a clinical prediction score for survival in patients with spinal metastases: the New England Spinal Metastasis Score.Spine J. 2021;21(1):28-36. doi:10.1016/j.spinee.2020.02.009
- [4]Xiong GX, Fisher MWA, Schwab JH, et al.: A Natural History of Patients Treated Operatively and Nonoperatively for Spinal Metastases Over 2Years Following Treatment: Survival and Functional Outcomes.Spine (Phila Pa 1976). 2022;47(7):515-522. doi:10.1097/BRS.0000000000004322
- [5]Wick JB, Kalistratova VS, Jr DP, et al.: A Comparison of Prognostic Models to Facilitate Surgical Decision-Making for Patients With Spinal Metastatic Disease.Spine (Phila Pa 1976). 2023;48(8):567-576. doi:10.1097/BRS.0000000000004600